Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference41 articles.
1. Balandraud N, Texier G, Massy E, Muis-Pistor O, Martin M, Auger I, et al. Long term treatment with abatacept or tocilizumab does not increase Epstein-Barr virus load in patients with rheumatoid arthritis - A three years’ retrospective study. PLoS One. 2017;12:e0171623.
2. Chaabo K, Kirkham B. Rheumatoid Arthritis-Anti-TNF. Int Immunopharmacol. 2015;27(2):180–4.
3. Bonafede MM, Curtis JR, McMorrow D, Mahajan P, Chen CI. Treatment effectiveness and treatment patterns among rheumatoid arthritis patients after switching from a tumor necrosis factor inhibitor to another medication. Clinicoecon Outcomes Res. 2016;8:707–15.
4. Singh JA, Saag KG, Bridges SL Jr, Akl EA, Bannuru RR, Sullivan MC, et al. 2015 American College of Rheumatology Guideline for the treatment of rheumatoid arthritis. Arthritis Rheum. 2016;68(1):1–26.
5. Bonafede M, Fox KM, Watson C, Princic N, Gandra SR. Treatment patterns in the first year after initiating tumor necrosis factor blockers in real-world settings. Adv Ther. 2012;29(8):664–74.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Experimental models of sarcoidosis: where are we now?;Current Opinion in Pulmonary Medicine;2020-07-21
2. Immunomodulators;Side Effects of Drugs Annual;2020